- Home
- Articles
- us virgislands
- drug supply
Refine by
Drug Supply Articles & Analysis
10 articles found
This new approach to treatment incorporates patient perspectives into drug development. A key benefit is the keener focus on convenience and safe drug administration. ...
*Pyrimidine Pyrimidine cyclic compounds have a variety of physiological activities and are the dominant structures in drug design. There are numerous active compounds with pyrimidine ring structure units that are contained in many commercially available and clinical drug molecules. ...
TPD drugs are one of the hot spots of new drug development in recent years, especially in the field of oncology. For example, a TPD drug developed by Arvinas has achieved proof-of-concept in clinical trials for the treatment of breast and prostate cancer. ...
Revisiting the “why” behind decision making can be a helpful exercise in all aspects of business. This is no less true for clinical operations executives when it comes to the clinical trial systems they employ to facilitate their teams’ work. The technology that supports clinical trial systems has evolved steadily over the past several decades, yet the ultimate goal of ...
Obtaining available cost data for the mRNA supply chain is not easy, so using some of the data from P-A Gilbert’s presentation, we calculate that a facility able to produce 100 M doses per year (100ug dosage, 50M patients) will have a capital budget of $14M and able to reach drug substance costs of $3/dose. ...
Brentwood is proud to partner with Penn State Health St. Joseph in Berks County’s fight against COVID-19. The company donated 5,000 reusable face shields to the hospital to protect healthcare workers as the pandemic continues. Brentwood President, Peter Rye, and his wife, Leigh, presented the donation to hospital representatives on Wednesday. “We wanted to protect those working to ...
The Drug Supply Chain Security Act (DSCSA) is Title II of the Drug Quality and Security Act (DQSA) and is designed to protect consumers from potentially harmful drugs. ...
The Drug Supply Chain Security Act (DSCSA) is Title II of the Drug Quality and Security Act (DQSA), which was enacted to enhance FDA’s ability to protect consumers from exposure to potentially harmful drugs. The act outlines steps to build an electronic, interoperable system to identify and trace certain prescription ...
Many hospitals struggle to achieve optimal compliance with the Drug Supply Chain Security Act (DSCSA). The challenge to comply seems to come from an incomplete or inaccurate understanding of the regulations, which is understandable given the Act’s complexity. ...
When the Drug Quality and Security Act (DQSA) was signed by President Obama on November 27, 2013, advocates hoped that the confusing patchwork of State laws governing drug pedigree and tracing would finally be replaced by a comprehensive solution for the ‘3T’s’ (Transaction History, Transaction Statement, and Transaction Information) of the ...